Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Clearside Biomedical Stock (NASDAQ: CLSD) stock price, news, charts, stock research, profile.
Open- | Close- |
Vol / Avg.0 / 110.131K | Mkt Cap53.191M |
Day Range- - - | 52 Wk Range0.825 - 1.850 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.150 | -0.0100 | ||||
REV | 120.000K | 1.018M | 898.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 5.00 |
2023-08-15 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
2023-08-15 | Needham | Serge Belanger | Reiterates | BuyBuy | Maintains | - | 4.00 |
2023-07-19 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
CLSD | Clearside Biomedical | -1.43% | 53.2M |
CPIX | Cumberland | 0% | 27.2M |
SCYX | SCYNEXIS | 3.07% | 87.4M |
OCUP | Ocuphire Pharma | 2.69% | 73M |
RANI | Rani Therapeutics Hldgs | 0.23% | 55.7M |
You can purchase shares of Clearside Biomedical (NASDAQ: CLSD) through any online brokerage.
Other companies in Clearside Biomedical’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Qilian Intl Hldg Gr (NASDAQ:QLI).
The latest price target for Clearside Biomedical (NASDAQ: CLSD) was reported by JMP Securities on Tuesday, August 15, 2023. The analyst firm set a price target for 5.00 expecting CLSD to rise to within 12 months (a possible 483.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Clearside Biomedical (NASDAQ: CLSD) is $0.8575 last updated September 29, 2023 at 11:00 AM UTC.
There is no dividend information for Clearside Biomedical.
Clearside Biomedical’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Clearside Biomedical.
Clearside Biomedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.